Physician profile
Abhishek Kumar
NPI 1427463058
$410,110.85
in general payments reported to CMS, 2019-2025
25 companies · $133K in 2025
The $133K reported for 2025 was more than what 99% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,504 · 2021: $8,798 · 2022: $24K · 2023: $80K · 2024: $149K · 2025: $133K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $273K · Consulting Fee: $41K · Travel and Lodging: $34K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $273,456.25 |
| Consulting Fee | $41,490.02 |
| Travel and Lodging | $34,277.38 |
| Food and Beverage | $12,311.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $377,580.04 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, General - Embolics, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Biocompatibles, INC. | $10,657.27 | 2019 | |
| Guerbet LLC | $8,261.47 | 2025 | Lipiodol |
| Balt USA, LLC | $5,166.99 | 2021-2025 | Prestige Coil System, Ballast 088 Long Sheath |
| Siemens Medical Solutions USA, INC. | $2,000.00 | 2025 | |
| Penumbra, INC. | $1,251.30 | 2019-2021 | |
| Inari Medical, INC. | $1,132.65 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic USA, INC. | $639.04 | 2019-2020 | |
| Cardiovascular Systems INC. | $577.86 | 2019-2023 | Diamondback Peripheral |
| Angiodynamics, INC. | $441.69 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $399.76 | 2021-2025 | Mo.Ma Ultra, Concertotm |
| Trisalus Life Sciences, INC. | $344.61 | 2025 | Trinav Infusion System |
| Stryker Corporation | $295.82 | 2025 | Artix Mt, Flowtriever |
| Imperative Care, INC | $252.67 | 2025 | Symphony Catheter |
| Okami Medical, INC. | $215.22 | 2025 | Lobo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $204.06 | 2020-2022 | |
| Abbott Laboratories | $178.15 | 2019-2022 | |
| Argon Medical Devices, INC. | $144.24 | 2022-2023 | Cleaner, Ivcf |
| Btg International Canada INC. | $124.51 | 2019 | |
| Alphatec Spine, INC | $56.85 | 2025 | Biologics |
| Cordis US Corp. | $47.59 | 2023 | Mynx Control, Aquatrack |
| Nuvasive, INC. | $43.85 | 2022 | |
| Sirtex Medical INC | $40.82 | 2022-2024 | Sir-Spheres Microspheres |
| Cook Medical LLC | $33.79 | 2019-2020 | |
| Terumo Medical Corporation | $20.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhishek Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.